Riskpilot← Back to searchSign inGet full accessMeditrans Oy
OYActiveY-tunnus 0710362-7B B 21Translation and interpretation activities · NACE 7430Est. 19883 employees
Revenue 2025
EUR 22K
EBITDA margin
341.5%
Equity ratio
90.7%
Financial strength
Net profit 2025
EUR -34K
3 employees
| Revenue | EUR 22K | — |
| EBITDA | EUR 76K | — |
| Net profit | EUR -34K | — |
| Total assets | EUR 103K | — |
| Equity | EUR 93K | — |
| Employees | 3 | — |
Legal name
Meditrans Oy
Y-tunnus number
0710362-7
Legal form
Osakeyhtiö
NACE code
7430 · Translation and interpretation activities
Founded
16. syyskuuta 1988
Share capital
EUR 2 523
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on kielitaitotehtävien kuten käännös-, tulkkaus- ja kielentarkastustehtävien sekä sihteerintehtävien suorittaminen.
Address
B B 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 179 | 154 | 114 | 97 | 87 | 0 | 22 |
| Staff expenses | −46 | −65 | −60 | −36 | −19 | −0 | 18 |
| EBITDA | 41 | 38 | 20 | 22 | 6 | 0 | 76 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 | −0 | — |
| EBIT | 41 | 38 | 20 | 22 | 6 | 0 | −31 |
| Net financials | −1 | −0 | −0 | −0 | −0 | 0 | — |
| Profit before tax | 40 | 37 | 19 | 22 | 5 | 0 | −32 |
| Tax | 9 | 8 | 3 | 6 | 1 | −0 | 2 |
| Net profit | 31 | 30 | 17 | 15 | 4 | 0 | −34 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 193 | 191 | 202 | 207 | 2 156 | 0 | 103 |
| Equity | 165 | 181 | 186 | 187 | 191 | 0 | 93 |
| Long-term debt | — | — | — | 0 | 0 | 0 | — |
| Short-term debt | 27 | 10 | 16 | 21 | 3 320 | 0 | 10 |
| Total debt | 27 | 10 | 16 | 21 | 33 | 0 | 10 |
EBITDA margin
341.5%
This company
15.8%
Market median
+2061% vs market
20192025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
20192025
Return on equity
-36.8%
This company
18.4%
Market median
-300% vs market
20192025
Net profit margin
-153.8%
This company
8.1%
Market median
-1999% vs market
20192025
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20192025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20192025
- Annual report 2025Filed via PRH / YTJ · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via PRH / YTJ · Period 2018-09-01 – 2019-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VK | Audit | 2013 | — | — |
AK Deputy auditor | Deputy auditor | 2013 | — | — |
AP Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
TM Deputy Member | Deputy Member | 2013 | — | — |
AP Chief Executive Officer | Chief Executive Officer | 1988 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Meditrans Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vieno Kaarina Mällönen | Audit | 0 companies |
| Anu Kristiina Björklund | Deputy auditor | 0 companies |
| Anita Paajanen-Mannila | Chief Executive Officer | 0 companies |
| Tuuli-Elina Mannila-Keitel | Deputy Member | 0 companies |
| Anita Paajanen-Mannila | Chief Executive Officer | 0 companies |